Modified citrus pectin (MCP) is a specific inhibitor of galectin-3 (Gal-3) that is regarded as a
new biomarker of cardiac hypertrophy, but its effect is unclear. The aim of this study is to …

Aims Pathological cardiac hypertrophy is a characteristic feature in many cardiovascular
diseases (CVDs). Aloin is an anthraquinone glycoside from Aloe species, and the effect of …

Aims Transglutaminase (TG) inhibitors represent promising therapeutic interventions in
cardiac fibrosis and related dysfunctions. However, it remains unknown how TG inhibition …

Cardiovascular diseases, the leading global cause of death, are usually associated with
cardiac hypertrophy (CH). CH is an adaptive response of the heart against cardiac …

Background Cardiac hypertrophy (CH) is a prevalent consequence of cardiovascular
disease, necessitating treatment with synthetic medications that often have adverse effects …

Objective: This study aimed to validate the synergistic effects of Cinnamomum verum (C.
verum) barks and stingless bee honey (SBH) against cardiac hypertrophy (CH). Materials …

Cardiac hypertrophy (CH), leading to cardiac failure is due to chronic metabolic alterations
occurring during cellular stress. Besides the already known relationship between oxidative …

Piper betle (Piperaceae family) has potent anti-diabetic and antioxidant activities and is
already reported to treat cardiovascular diseases. This study assesses the intervening effect …

Cardiac hypertrophy (CH), leading to cardiac failure is due to chronic metabolic alterations
occurring during cellular stress. Besides the already known relationship between oxidative …

Background: Cardiac hypertrophy (CH) is the asymptomatic enlargement of ventricular walls
witnessed in diabetes and hypertension, for which early metabolite differences and …